Evidence map›Paper›PMID 35455941›Full record

ReviewCells2022

Laura Smith, Anthony H V Schapira

Open access · goldAbstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Cells, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 145 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
145citing papers in PubMed, 4 pooled it
25.8field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

145 citing papers in PubMed, 4 syntheses or guidelines pooled it, 240 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Review
  11. Review
  12. Review
  13. Article
  14. Article
  15. Article
  16. Review
  17. Review
  18. Dual-Risk axis:Journal of Parkinson's disease · 2026
    Article
  19. Review
  20. Review

85 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 2 countries.

Laura SmithDepartment of Clinical and Movement Neurosciences, Institute of Neurology, University College London, London NW3 2PF, UK.ORCID 0000-0002-1108-2991
Anthony H V SchapiraDepartment of Clinical and Movement Neurosciences, Institute of Neurology, University College London, London NW3 2PF, UK.
Research Network (United States) · US

Funding

Department of HealthMedical Research Council MR/T046007/1
6 · The paper itself

Abstract

The

Indexed as

alpha-SynucleinGlucosylceramidaseParkinson DiseaseEndoplasmic ReticulumHumansLysosomesMutationalpha-SynucleinGBA protein, humanGlucosylceramidasealpha-synucleinautophagyGBAlipidsParkinson diseaseunfolded protein response

Identifiers

PMID35455941
PMCPMC9029385
OpenAlexW4224297855

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.